FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4365142419> ?p ?o ?g. }

• W4365142419 endingPage "2242" @default.
• W4365142419 startingPage "2242" @default.
• W4365142419 abstract "Background: In differentiated thyroid cancer (DTC) patients, the response to initial treatments is evaluated 6-12 months after radioiodine therapy (RIT) according to the 2015 American Thyroid Association (2015 ATA) criteria. In selected patients, diagnostic 131-radioiodine whole-body scintigraphy (Dx-WBS) is recommended. We evaluated the diagnostic performance of 123I-Dx-WBS-SPECT/CT imaging in detecting incomplete structural responses in the early follow-up of DTC patients and, additionally, derived optimized basal-Tg value as a yardstick for scintigraphic imaging. Methods: We reviewed the records of 124 low or intermediate-risk DTC patients with negative anti-thyroglobulin antibody. All patients had undergone (near)-total-thyroidectomy followed by RIT. The response to initial treatments was evaluated 6-12 months after RIT. Results: According to the 2015 ATA criteria, 87, 19 and 18 DTC patients were classified to have excellent response (ER), indeterminate/incomplete biochemical response (BIndR/BIR) or structural incomplete response (SIR), respectively. Among patients with less than ER, 18 had a positive 123I-Dx-WBS-SPECT/CT. Metastatic disease at 123I-Dx-WBS-SPECT/CT mainly involved lymph nodes within the central compartment, and corresponding neck ultrasound examinations were negative. The ROC curve analysis was performed to define the best basal-Tg cut-off (i.e., 0.39 ng/mL; AUC = 0.852) able to discriminate patients with and without positive 123I-Dx-WBS-SPECT/CT, respectively. The overall sensitivity, specificity, accuracy, PPV and NPV were 77.8%, 89.6%, 87.9%, 56.0% and 95.9%, respectively. Basal-Tg cut-off was an independent risk factor for having a positive 123I-Dx-WBS-SPECT/CT. Conclusion:123I-Dx-WBS-SPECT/CT identified lymph node metastases in 14/37 patients with less than ER and a negative neck ultrasound, thus modifying the management of such patients. The diagnostic performance of 123I-Dx-WBS-SPECT/CT significantly increased in patients with basal-Tg values ≥ 0.39 ng/mL." @default.
• W4365142419 created "2023-04-13" @default.
• W4365142419 creator A5004720486 @default.
• W4365142419 creator A5007284506 @default.
• W4365142419 creator A5011627914 @default.
• W4365142419 creator A5019705129 @default.
• W4365142419 creator A5043829370 @default.
• W4365142419 creator A5044351572 @default.
• W4365142419 creator A5052879426 @default.
• W4365142419 creator A5057334553 @default.
• W4365142419 creator A5057411375 @default.
• W4365142419 creator A5067420437 @default.
• W4365142419 creator A5083119516 @default.
• W4365142419 creator A5083590917 @default.
• W4365142419 creator A5090049994 @default.
• W4365142419 date "2023-04-11" @default.
• W4365142419 modified "2023-09-25" @default.
• W4365142419 title "Thyroglobulin Value Predict Iodine-123 Imaging Result in Differentiated Thyroid Cancer Patients" @default.
• W4365142419 cites W1503618018 @default.
• W4365142419 cites W1981154477 @default.
• W4365142419 cites W1984091239 @default.
• W4365142419 cites W2029563033 @default.
• W4365142419 cites W2033882181 @default.
• W4365142419 cites W2071975634 @default.
• W4365142419 cites W2116542352 @default.
• W4365142419 cites W2128409695 @default.
• W4365142419 cites W2129653636 @default.
• W4365142419 cites W2145150141 @default.
• W4365142419 cites W2145429648 @default.
• W4365142419 cites W2162016274 @default.
• W4365142419 cites W2163175491 @default.
• W4365142419 cites W2409881910 @default.
• W4365142419 cites W2415655427 @default.
• W4365142419 cites W2557693039 @default.
• W4365142419 cites W2582779552 @default.
• W4365142419 cites W2585636819 @default.
• W4365142419 cites W2603577764 @default.
• W4365142419 cites W2757322914 @default.
• W4365142419 cites W2789833338 @default.
• W4365142419 cites W2795948878 @default.
• W4365142419 cites W2923440107 @default.
• W4365142419 cites W2954627864 @default.
• W4365142419 cites W3011511383 @default.
• W4365142419 cites W3048147076 @default.
• W4365142419 cites W3119005666 @default.
• W4365142419 cites W3121043775 @default.
• W4365142419 cites W3159300532 @default.
• W4365142419 cites W3179803143 @default.
• W4365142419 doi "https://doi.org/10.3390/cancers15082242" @default.
• W4365142419 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37190170" @default.
• W4365142419 hasPublicationYear "2023" @default.
• W4365142419 type Work @default.
• W4365142419 citedByCount "0" @default.
• W4365142419 crossrefType "journal-article" @default.
• W4365142419 hasAuthorship W4365142419A5004720486 @default.
• W4365142419 hasAuthorship W4365142419A5007284506 @default.
• W4365142419 hasAuthorship W4365142419A5011627914 @default.
• W4365142419 hasAuthorship W4365142419A5019705129 @default.
• W4365142419 hasAuthorship W4365142419A5043829370 @default.
• W4365142419 hasAuthorship W4365142419A5044351572 @default.
• W4365142419 hasAuthorship W4365142419A5052879426 @default.
• W4365142419 hasAuthorship W4365142419A5057334553 @default.
• W4365142419 hasAuthorship W4365142419A5057411375 @default.
• W4365142419 hasAuthorship W4365142419A5067420437 @default.
• W4365142419 hasAuthorship W4365142419A5083119516 @default.
• W4365142419 hasAuthorship W4365142419A5083590917 @default.
• W4365142419 hasAuthorship W4365142419A5090049994 @default.
• W4365142419 hasBestOaLocation W43651424191 @default.
• W4365142419 hasConcept C126322002 @default.
• W4365142419 hasConcept C126838900 @default.
• W4365142419 hasConcept C2777074255 @default.
• W4365142419 hasConcept C2778024521 @default.
• W4365142419 hasConcept C2778835679 @default.
• W4365142419 hasConcept C2779306644 @default.
• W4365142419 hasConcept C2779761222 @default.
• W4365142419 hasConcept C2779902710 @default.
• W4365142419 hasConcept C2989005 @default.
• W4365142419 hasConcept C2993294228 @default.
• W4365142419 hasConcept C526584372 @default.
• W4365142419 hasConcept C71924100 @default.
• W4365142419 hasConceptScore W4365142419C126322002 @default.
• W4365142419 hasConceptScore W4365142419C126838900 @default.
• W4365142419 hasConceptScore W4365142419C2777074255 @default.
• W4365142419 hasConceptScore W4365142419C2778024521 @default.
• W4365142419 hasConceptScore W4365142419C2778835679 @default.
• W4365142419 hasConceptScore W4365142419C2779306644 @default.
• W4365142419 hasConceptScore W4365142419C2779761222 @default.
• W4365142419 hasConceptScore W4365142419C2779902710 @default.
• W4365142419 hasConceptScore W4365142419C2989005 @default.
• W4365142419 hasConceptScore W4365142419C2993294228 @default.
• W4365142419 hasConceptScore W4365142419C526584372 @default.
• W4365142419 hasConceptScore W4365142419C71924100 @default.
• W4365142419 hasIssue "8" @default.
• W4365142419 hasLocation W43651424191 @default.
• W4365142419 hasLocation W43651424192 @default.
• W4365142419 hasLocation W43651424193 @default.
• W4365142419 hasOpenAccess W4365142419 @default.
• W4365142419 hasPrimaryLocation W43651424191 @default.

• next